-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2010 to 2022.
- Horizon Therapeutics Public Ltd Co Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending June 30, 2023 was $142M, a 133% increase year-over-year.
- Horizon Therapeutics Public Ltd Co Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending June 30, 2023 was $475M, a 36.8% decline year-over-year.
- Horizon Therapeutics Public Ltd Co annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was $549M, a 5.65% increase from 2021.
- Horizon Therapeutics Public Ltd Co annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was $520M, a 32.7% increase from 2020.
- Horizon Therapeutics Public Ltd Co annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2020 was $392M, a 31.6% decline from 2019.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)